Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
945.90
1,085.82
876.90
835.58
938.04
1,132.97
1,000.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
945.90
1,085.82
876.90
835.58
938.04
1,132.97
1,000.34
Raw Material Cost
532.98
677.05
600.59
442.78
552.50
679.59
634.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.09
11.15
13.51
15.83
17.18
22.49
20.16
Selling and Distribution Expenses
148.45
165.15
117.77
165.75
67.54
126.02
104.19
Other Expenses
10.08
5.37
4.77
9.01
1.69
6.39
4.17
Total Expenditure (Excl Depreciation)
800.28
907.05
779.56
714.46
654.17
891.96
800.42
Operating Profit (PBDIT) excl Other Income
145.6
178.79999999999998
97.30000000000001
121.1
283.9
241
199.89999999999998
Other Income
2.13
-6.92
4.19
86.43
-33.67
45.73
24.95
Operating Profit (PBDIT)
157.73
280.04
160.24
362.33
299.99
324.47
262.59
Interest
18.09
11.15
13.51
15.83
17.18
22.49
20.16
Exceptional Items
12.29
7.26
2.03
-15.21
14.27
-5.08
-4.21
Gross Profit (PBDT)
412.92
408.77
276.31
392.80
385.53
453.39
365.93
Depreciation
0.00
58.72
58.72
49.80
49.80
37.72
37.72
Profit Before Tax
151.93
217.42
90.05
281.49
247.28
259.17
200.49
Tax
8.73
15.87
8.03
64.76
46.52
31.35
23.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
143.20
201.55
84.71
220.36
200.77
227.83
177.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
143.20
201.55
84.71
220.36
200.77
227.83
177.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
-0.00
-0.00
-0.04
-0.01
0.00
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
143.19
201.55
84.71
220.32
200.76
227.83
177.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,754.71
6,605.63
6,576.88
6,491.67
6,270.41
6,070.04
5,982.03
Earnings per share (EPS)
0.09
0.13
0.05
0.12
0.12
0.14
0.11
Diluted Earnings per share
0.09
0.13
0.05
0.12
0.12
0.14
0.11
Operating Profit Margin (Excl OI)
16.45%
21.02%
11.1%
27.06%
30.26%
21.27%
19.99%
Gross Profit Margin
16.06%
25.43%
16.96%
39.65%
31.67%
26.21%
23.81%
PAT Margin
15.14%
18.56%
9.66%
26.37%
21.4%
20.11%
17.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -12.88% vs 23.82% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -28.97% vs 138.02% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -45.78% vs 83.86% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 61.61% vs -17.04% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
945.90
0
945.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
945.90
0
945.90
Raw Material Cost
532.98
0
532.98
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.09
0
18.09
Selling and Distribution Expenses
148.45
0
148.45
Other Expenses
10.08
0.00
10.08
Total Expenditure (Excl Depreciation)
800.28
0
800.28
Operating Profit (PBDIT) excl Other Income
145.62
0.00
145.62
Other Income
2.13
0
2.13
Operating Profit (PBDIT)
157.73
0
157.73
Interest
18.09
0
18.09
Exceptional Items
12.29
0
12.29
Gross Profit (PBDT)
412.92
0
412.92
Depreciation
0.00
0
0.00
Profit Before Tax
151.93
0
151.93
Tax
8.73
0
8.73
Provisions and contingencies
0
0
0.00
Profit After Tax
143.20
0
143.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
143.20
0
143.20
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.01
0
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
143.19
0
143.19
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,754.71
0
6,754.71
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
16.45%
0%
0.00
16.45%
Gross Profit Margin
16.06%
0%
0.00
16.06%
PAT Margin
15.14%
0%
0.00
15.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 94.59 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -12.88% vs 23.82% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.84% vs 11.91% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.32 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -28.97% vs 138.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -28.69% vs -6.52% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.56 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -45.78% vs 83.86% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -53.37% vs 11.75% in Sep 2024
Quarterly - Interest
Interest 1.81 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 61.61% vs -17.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.23% vs -29.22% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.45%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
